Price $480.17 |
Market Cap
173.35B
|
Sector Health Care |
Div. Growth
12.90%
|
|
P/E
46.7
|
P/B
5.75
|
P/S
6.55
|
Dividend %
0.20%
|
|
P/CF
49.2
|
P/FCF
44.4
|
Op. Cash Flow
5.27M
|
FCF
9.7
|
|
Op. Margin
17.00%
|
Net Margin
14.10%
|
ROE
12.60%
|
ROI
8.50%
|
|
ROA
6.30%
|
EPS Growth
5.40%
|
Current Ratio
1.9
|
Debt/Equity
57.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc (ESPR) | $32.31 | - | - | 995M | Strong Buy |
| MEDNAX Inc (MD) | $14.63 | - | - | 1.39B | Strong Buy |
| Mallinckrodt PLC (MNK) | $0.75 | - | - | 81.2M | Strong Buy |
| Endo International PLC (ENDP) | $5.79 | - | - | 765.3M | Strong Buy |
| Lannett Company, Inc. (LCI) | $7.01 | - | - | 244.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
